All Stories

  1. Unravelling the heterogeneous HCC risk in indeterminate chronic hepatitis B

    Article • Gut, August 2025, BMJ

    Dr Chien-Wei Su

  2. Gender Different Impacts of Muscle Mass and Adipose Tissue on Patients With Hepatocellular Carcinoma Undergoing Surgical Resection

    Article • Liver International, January 2025, Wiley

    Dr Chien-Wei Su

  3. Correspondence to letter to the editor 1 on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”

    Article • Clinical and Molecular Hepatology, January 2025, The Korean Association for the Study of the Liver (KAMJE)

    Dr Chien-Wei Su

  4. Correspondence to letter to the editor 2 on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”

    Article • Clinical and Molecular Hepatology, January 2025, The Korean Association for the Study of the Liver (KAMJE)

    Dr Chien-Wei Su

  5. Proton pump inhibitors use and risk of liver cancer: Concerns to be addressed

    Article • Advances in Digestive Medicine, December 2024, Wiley

    Dr Chien-Wei Su

  6. Correspondence to editorial on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”

    Article • Clinical and Molecular Hepatology, October 2024, The Korean Association for the Study of the Liver (KAMJE)

    Dr Chien-Wei Su

  7. Reply to “Association between proton‐pump inhibitor use and recurrence of hepatocellular carcinoma after hepatectomy: concerns to be addressed”

    Article • Journal of Gastroenterology and Hepatology, September 2024, Wiley

    Dr Chien-Wei Su

  8. Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma

    Article • Clinical and Molecular Hepatology, July 2024, The Korean Association for the Study of the Liver (KAMJE)

    Dr Chien-Wei Su

  9. The association between proton‐pump inhibitor use and recurrence of hepatocellular carcinoma after hepatectomy

    Article • Journal of Gastroenterology and Hepatology, June 2024, Wiley

    Dr Chien-Wei Su

  10. Prognostic Nutritional Index as a Prognostic Factor for Very Early-Stage Hepatocellular Carcinoma

    Article • Clinical and Translational Gastroenterology, April 2024, Wolters Kluwer Health

    Dr Chien-Wei Su

  11. Risk factors associated with hepatitis D virus infection and preventive strategies in Mongolia

    Article • Journal of the Chinese Medical Association, February 2024, Wolters Kluwer Health

    Dr Chien-Wei Su

  12. Analyzing risk factors and developing a stratification system for hepatocellular carcinoma recurrence after interferon-free direct-acting antiviral therapy in chronic hepatitis C patients

    Article • Journal of the Chinese Medical Association, January 2024, Wolters Kluwer Health

    Dr Chien-Wei Su

  13. Albumin-Based Liver Reserve Models vs. MELD 3.0 in Prognostic Prediction for Hepatocellular Carcinoma Patients with Renal Insufficiency

    Article • International Journal of Molecular Sciences, November 2023, MDPI AG

    Dr Chien-Wei Su

  14. Surgical resection versus transarterial chemoembolization for patients with hepatocellular carcinoma beyond Milan criteria: prognostic role of tumor burden score

    Article • Scientific Reports, August 2023, Springer Science + Business Media

    Dr Chien-Wei Su

  15. The outcomes and prognostic factors of patients with hepatocellular carcinoma and Child-Turcotte-Pugh class B

    Article • Journal of the Chinese Medical Association, August 2023, Wolters Kluwer Health

    Dr Chien-Wei Su

  16. The outcomes and prognostic factors of patients with hepatocellular carcinoma and normal serum alpha fetoprotein levels

    Article • Journal of the Formosan Medical Association, July 2023, Elsevier

    Dr Chien-Wei Su

  17. Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

    Article • Cancers, March 2023, MDPI AG

    Dr Chien-Wei Su

  18. Entecavir versus tenofovir on prognosis of hepatitis B virus‐related hepatocellular carcinoma after curative hepatectomy

    Article • Alimentary Pharmacology & Therapeutics, March 2023, Wiley

    Dr Chien-Wei Su

  19. Stronger Neo‐Minophagen C (SNMC): A stronger adjuvant for TACE?

    Article • Advances in Digestive Medicine, March 2023, Wiley

    Dr Chien-Wei Su

  20. Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade

    Article • Cancers, January 2023, MDPI AG

    Dr Chien-Wei Su

  21. Outcomes of atezolizumab and bevacizumab for hepatocellular carcinoma: Does age matter?

    Article • Liver International, November 2022, Wiley

    Dr Chien-Wei Su

  22. Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment

    Article • Viruses, October 2022, MDPI AG

    Dr Chien-Wei Su

  23. Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy

    Article • International Journal of Molecular Sciences, September 2022, MDPI AG

    Dr Chien-Wei Su

  24. Tumor burden score as a new prognostic surrogate in patients with hepatocellular carcinoma undergoing radiofrequency ablation: role of albumin-bilirubin (ALBI) grade vs easy ALBI grade

    Article • Expert Review of Gastroenterology & Hepatology, September 2022, Taylor & Francis

    Dr Chien-Wei Su

  25. Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden Score

    Article • Cancers, August 2022, MDPI AG

    Dr Chien-Wei Su

  26. Cryptogenic hepatocellular carcinoma: characteristics, outcome, and prognostic role of albumin-bilirubin (ALBI) grade vs easy ALBI grade

    Article • Scandinavian Journal of Gastroenterology, July 2022, Taylor & Francis

    Dr Chien-Wei Su

  27. Splenic artery pseudoaneurysm as a fatal complication of acute pancreatitis

    Article • Advances in Digestive Medicine, July 2022, Wiley

    Dr Chien-Wei Su

  28. Comparison of prognoses between cirrhotic and noncirrhotic patients with hepatocellular carcinoma and esophageal varices undergoing surgical resection

    Article • Journal of the Chinese Medical Association, June 2022, Wolters Kluwer Health

    Dr Chien-Wei Su

  29. Surgical resection could provide better outcomes for patients with hepatocellular carcinoma and tumor rupture

    Article • Scientific Reports, May 2022, Springer Science + Business Media

    Dr Chien-Wei Su

  30. Differential prognoses among male and female patients with hepatocellular carcinoma

    Article • Journal of the Chinese Medical Association, May 2022, Wolters Kluwer Health

    Dr Chien-Wei Su

  31. Upregulation of USP22 and ABCC1 during Sorafenib Treatment of Hepatocellular Carcinoma Contribute to Development of Resistance

    Article • Cells, February 2022, MDPI AG

    Dr Chien-Wei Su

  32. Dual hepatitis B and C-associated hepatocellular carcinoma: clinical characteristics, outcome, and prognostic role of albumin–bilirubin grade

    Article • International Journal of Clinical Oncology, February 2022, Springer Science + Business Media

    Dr Chien-Wei Su

  33. A New Tumor Burden Score and Albumin–Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma

    Article • Cancers, January 2022, MDPI AG

    Dr Chien-Wei Su

  34. Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma

    Article • Therapeutic Advances in Medical Oncology, January 2022, SAGE Publications

    Dr Chien-Wei Su

  35. Liver Tumor Encapsulating the Gallbladder

    Article • Gastro Hep Advances, January 2022, Elsevier

    Dr Chien-Wei Su

  36. Sofosbuvir-based antiviral therapy provided highly treatment efficacy, safety, and good tolerability for Taiwanese chronic hepatitis C patients with decompensated cirrhosis

    Article • Journal of the Chinese Medical Association, November 2021, Wolters Kluwer Health

    Dr Chien-Wei Su

  37. Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

    Article • Hepatology International, November 2021, Springer Science + Business Media

    Dr Chien-Wei Su

  38. Virological and immunological predictors of long term outcomes of peginterferon alfa-2a therapy for HBeAg-negative chronic hepatitis B

    Article • Journal of the Formosan Medical Association, September 2021, Elsevier

    Dr Chien-Wei Su

  39. Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection

    Article • Cancers, August 2021, MDPI AG

    Dr Chien-Wei Su

  40. Hepatitis D virus dual infection increased the risk of hepatocellular carcinoma compared with hepatitis B virus mono infection: A meta-analysis

    Article • Journal of the Chinese Medical Association, August 2021, Wolters Kluwer Health

    Dr Chien-Wei Su

  41. Early and late recurrence of surgically resected hepatitis B virus-related hepatocellular carcinoma on nucleos(t)ide analogues therapy

    Article • Journal of the Formosan Medical Association, August 2021, Elsevier

    Dr Chien-Wei Su

  42. Tumor burden score as a new prognostic marker for patients with hepatocellular carcinoma undergoing transarterial chemoembolization

    Article • Journal of Gastroenterology and Hepatology, July 2021, Wiley

    Dr Chien-Wei Su

  43. Easy albumin–bilirubin score as a new prognostic predictor in hepatocellular carcinoma

    Article • Hepatology Research, June 2021, Wiley

    Dr Chien-Wei Su

  44. Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan

    Article • Journal of Microbiology Immunology and Infection, June 2021, Elsevier

    Dr Chien-Wei Su

  45. Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development

    Article • Hepatology, May 2021, Wolters Kluwer Health

    Dr Chien-Wei Su

  46. Persistent liver inflammation in chronic hepatitis C patients with advanced fibrosis after direct-acting antivirals induced sustained virological response

    Article • Journal of the Chinese Medical Association, April 2021, Wolters Kluwer Health

    Dr Chien-Wei Su

  47. Well tolerability and highly effective treatment response for hepatitis C virus-human immunodeficiency virus–coinfected patients treated by all-oral direct-acting antivirals

    Article • Journal of the Chinese Medical Association, April 2021, Wolters Kluwer Health

    Dr Chien-Wei Su

  48. Right inguinal metastasis from hepatocellular carcinoma

    Article • Advances in Digestive Medicine, April 2021, Wiley

    Dr Chien-Wei Su

  49. Tertiary Prevention of HCC in Chronic Hepatitis B or C Infected Patients

    Article • Cancers, April 2021, MDPI AG

    Dr Chien-Wei Su

  50. ALBI grade in dialysis patients with hepatocellular carcinoma: prognostic impact and staging strategy

    Article • Journal of Gastrointestinal Oncology, April 2021, AME Publishing Company

    Dr Chien-Wei Su

  51. Toward a new landscape for the mechanism of immunosuppression in hepatocellular carcinoma

    Article • Hepatology International, March 2021, Springer Science + Business Media

    Dr Chien-Wei Su

  52. Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C

    Article • Journal of the Formosan Medical Association, March 2021, Elsevier

    Dr Chien-Wei Su

  53. The role of albumin–bilirubin grade in determining the outcomes of patients with very early-stage hepatocellular carcinoma

    Article • Journal of the Chinese Medical Association, February 2021, Wolters Kluwer Health

    Dr Chien-Wei Su

  54. Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B

    Article • Hepatology International, October 2020, Springer Science + Business Media

    Dr Chien-Wei Su

  55. Author Correction: Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinoma

    Article • Scientific Reports, October 2020, Springer Science + Business Media

    Dr Chien-Wei Su

  56. A comparison of prognoses between surgical resection and radiofrequency ablation therapy for patients with hepatocellular carcinoma and esophagogastric varices

    Article • Scientific Reports, October 2020, Springer Science + Business Media

    Dr Chien-Wei Su

  57. A clinical trial with valproic acid and hydralazine in combination with gemcitabine and cisplatin followed by doxorubicin and dacarbazine for advanced hepatocellular carcinoma

    Article • Asia-Pacific Journal of Clinical Oncology, September 2020, Wiley

    Dr Chien-Wei Su

  58. Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma

    Article • Liver International, June 2020, Wiley

    Dr Chien-Wei Su

  59. Albumin–Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

    Article • Digestive Diseases and Sciences, June 2020, Springer Science + Business Media

    Dr Chien-Wei Su

  60. Survival of Patients with Hepatocellular Carcinoma in Renal Insufficiency: Prognostic Role of Albumin-Bilirubin Grade

    Article • Cancers, April 2020, MDPI AG

    Dr Chien-Wei Su

  61. Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinoma

    Article • Scientific Reports, March 2020, Springer Science + Business Media

    Dr Chien-Wei Su

  62. Comparison of prognosis between surgical resection and transarterial chemoembolization for patients with solitary huge hepatocellular carcinoma

    Article • Annals of Translational Medicine, March 2020, AME Publishing Company

    Dr Chien-Wei Su

  63. Low dose of propranolol treatment is associated with better survival in cirrhotic patients with hepatic encephalopathy

    Article • European Journal of Gastroenterology & Hepatology, March 2020, Wolters Kluwer Health

    Dr Chien-Wei Su

  64. Liver stiffness measured by acoustic radiation force impulse elastography predicted prognoses of hepatocellular carcinoma after radiofrequency ablation

    Article • Scientific Reports, February 2020, Springer Science + Business Media

    Dr Chien-Wei Su

  65. Association between esophagogastric varices in hepatocellular carcinoma and poor prognosis after transarterial chemoembolization: A propensity score matching analysis

    Article • Journal of the Formosan Medical Association, February 2020, Elsevier

    Dr Chien-Wei Su

  66. Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease

    Article • Obesity Surgery, January 2020, Springer Science + Business Media

    Dr Chien-Wei Su

  67. The correlation between fatty liver disease and chronic kidney disease

    Article • Journal of the Formosan Medical Association, January 2020, Elsevier

    Dr Chien-Wei Su

  68. Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection

    Article • Journal of the Formosan Medical Association, January 2020, Elsevier

    Dr Chien-Wei Su

  69. Highly effective treatment response and well tolerability by all oral direct acting antivirals for chronic hepatitis C patients post organ transplantation

    Article • Journal of the Chinese Medical Association, January 2020, Wolters Kluwer Health

    Dr Chien-Wei Su

  70. Towards a more comprehensive evaluation of liver fibrosis in patients with chronic hepatitis C

    Article • Journal of the Chinese Medical Association, November 2019, Wolters Kluwer Health

    Dr Chien-Wei Su

  71. A New Prognostic Model Based on Albumin–Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria

    Article • Digestive Diseases and Sciences, October 2019, Springer Science + Business Media

    Dr Chien-Wei Su

  72. High Expression of MicroRNA-196a is Associated with Progression of Hepatocellular Carcinoma in Younger Patients

    Article • Cancers, October 2019, MDPI AG

    Dr Chien-Wei Su

  73. Albumin‐bilirubin grade‐based nomogram of the BCLC system for personalized prognostic prediction in hepatocellular carcinoma

    Article • Liver International, September 2019, Wiley

    Dr Chien-Wei Su

  74. Daclatasvir plus sofosbuvir, with or without ribavirin, is highly effective for all kinds of genotype-2 chronic hepatitis-C infection in Taiwan

    Article • Journal of the Chinese Medical Association, September 2019, Wolters Kluwer Health

    Dr Chien-Wei Su

  75. A new ALBI‐based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma

    Article • Liver International, July 2019, Wiley

    Dr Chien-Wei Su

  76. A Novel AURKA Mutant-Induced Early-Onset Severe Hepatocarcinogenesis Greater than Wild-Type via Activating Different Pathways in Zebrafish

    Article • Cancers, July 2019, MDPI AG

    Dr Chien-Wei Su

  77. Less barium enema, more colonoscopy

    Article • Journal of the Chinese Medical Association, April 2019, Wolters Kluwer Health

    Dr Chien-Wei Su

  78. A 12-week rescue therapy by PrOD-based regimen for advanced fibrotic genotype-1 CHC patients who failed to pegylated interferon plus ribavirin

    Article • Journal of the Chinese Medical Association, March 2019, Wolters Kluwer Health

    Dr Chien-Wei Su

  79. Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B or C

    Article • Hepatology, February 2019, Wolters Kluwer Health

    Dr Chien-Wei Su

  80. Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions

    Article • Journal of the Formosan Medical Association, February 2019, Elsevier

    Dr Chien-Wei Su

  81. Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy

    Article • Journal of the Chinese Medical Association, January 2019, Wolters Kluwer Health

    Dr Chien-Wei Su

  82. Esophageal varices are not predictive of patient prognosis after surgical resection of hepatocellular carcinoma

    Article • European Journal of Gastroenterology & Hepatology, November 2018, Wolters Kluwer Health

    Dr Chien-Wei Su

  83. Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma

    Article • Scientific Reports, October 2018, Springer Science + Business Media

    Dr Chien-Wei Su

  84. Lymphoid Enhancer Factor 1 Contributes to Hepatocellular Carcinoma Progression Through Transcriptional Regulation of Epithelial-Mesenchymal Transition Regulators and Stemness Genes

    Article • Hepatology Communications, September 2018, Wiley

    Dr Chien-Wei Su

  85. Risk of renal events during tenofovir disoproxil fumarate and entecavir antiviral prophylaxis in HBsAg-positive cancer patients undergoing chemotherapy

    Article • Journal of Viral Hepatitis, September 2018, Wiley

    Dr Chien-Wei Su, Yi-Hsiang Huang

  86. Combination of albumin-bilirubin grade and platelets to predict a compensated patient with hepatocellular carcinoma who does not require endoscopic screening for esophageal varices

    Article • Gastrointestinal Endoscopy, August 2018, Elsevier

    Dr Chien-Wei Su

  87. Incidence and Predictors of HBsAg Loss After Peginterferon Therapy in HBeAg-Negative Chronic Hepatitis B: A Multicenter, Long-term Follow-up Study

    Article • The Journal of Infectious Diseases, May 2018, Oxford University Press (OUP)

    Dr Chien-Wei Su

  88. Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan

    Article • Journal of the Formosan Medical Association, May 2018, Elsevier

    Dr Chien-Wei Su

  89. Same-day Versus Split-dose Bowel Preparation Before Colonoscopy

    Article • Journal of Clinical Gastroenterology, May 2018, Wolters Kluwer Health

    Dr Chien-Wei Su

  90. Letter: the role of direct‐acting anti‐virals in determining the risk of hepatocellular carcinoma development in patients with hepatitis C virus‐induced cirrhosis

    Article • Alimentary Pharmacology & Therapeutics, March 2018, Wiley

    Dr Chien-Wei Su

  91. Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection

    Article • Scientific Reports, March 2018, Springer Science + Business Media

    Dr Chien-Wei Su

  92. Outcomes of resection surgery for hepatocellular carcinoma: Does size matter?

    Article • Journal of the Chinese Medical Association, February 2018, Wolters Kluwer Health

    Dr Chien-Wei Su

  93. Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation

    Article • Scientific Reports, January 2018, Springer Science + Business Media

    Dr Chien-Wei Su

  94. The Prognosis of Single Large Hepatocellular Carcinoma Was Distinct from Barcelona Clinic Liver Cancer Stage A or B: The Role of Albumin-Bilirubin Grade

    Article • Liver Cancer, January 2018, Karger Publishers

    Dr Chien-Wei Su

  95. Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure

    Article • PLOS One, November 2017, PLOS

    Dr Chien-Wei Su

  96. Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation

    Article • Radiology, November 2017, Radiological Society of North America (RSNA)

    Dr Chien-Wei Su

  97. Acute kidney injury predicts mortality in cirrhotic patients with gastric variceal bleeding

    Article • Journal of Gastroenterology and Hepatology, October 2017, Wiley

    Dr Chien-Wei Su

  98. Validation of the albumin-bilirubin grade-based integrated model as a predictor for sorafenib-failed hepatocellular carcinoma

    Article • Liver International, August 2017, Wiley

    Dr Chien-Wei Su, Yi-Hsiang Huang

  99. Impact of etiological treatment on prognosis

    Article • Hepatology International, July 2017, Springer Science + Business Media

    Dr Chien-Wei Su

  100. Interval to vascularization development in cirrhotic precursor nodules in patients with hepatitis B and C virus co-infections

    Article • PLOS One, June 2017, PLOS

    Dr Chien-Wei Su

  101. Higher platelet counts are associated with metabolic syndrome independent of fatty liver diagnosis

    Article • Journal of the Chinese Medical Association, March 2017, Wolters Kluwer Health

    Dr Chien-Wei Su

  102. The impact of esophagogastric varices on the prognosis of patients with hepatocellular carcinoma

    Article • Scientific Reports, February 2017, Springer Science + Business Media

    Dr Chien-Wei Su

  103. Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease

    Article • Gastroenterology Research and Practice, January 2017, Hindawi Publishing Corporation

    Dr Chien-Wei Su

  104. Clinical efficacy of Rong-Yang-Jyh-Gan-Tang on patients with chronic hepatitis C: A double-blinded randomized placebo-controlled crossover study

    Article • Journal of Ethnopharmacology, January 2017, Elsevier

    Dr Chien-Wei Su

  105. The impact of clinically significant portal hypertension on the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation: a propensity score matching analysis

    Article • European Radiology, September 2016, Springer Science + Business Media

    Dr Chien-Wei Su

  106. Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patients

    Article • European Journal of Cancer, August 2016, Elsevier

    Dr Chien-Wei Su

  107. Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis

    Article • Scientific Reports, July 2016, Springer Science + Business Media

    Dr Chien-Wei Su

  108. Solitary Large Hepatocellular Carcinoma: Staging and Treatment Strategy

    Article • PLOS One, May 2016, PLOS

    Dr Chien-Wei Su

  109. Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems

    Article • Journal of Hepatology, March 2016, Elsevier

    Dr Chien-Wei Su

  110. Staging for hepatocellular carcinoma: An embarrassment of riches

    Article • Journal of Hepatology, March 2016, Elsevier

    Dr Chien-Wei Su

  111. The Effectiveness of ART Score in Selecting Patients for Transarterial Chemoembolization Retreatment

    Article • Medicine, November 2015, Wolters Kluwer Health

    Dr Chien-Wei Su

  112. Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma

    Article • Medicine, October 2015, Wolters Kluwer Health

    Dr Chien-Wei Su

  113. When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?

    Article • Medicine, October 2015, Wolters Kluwer Health

    Dr Chien-Wei Su

  114. Prognosis of Early-Stage Hepatocellular Carcinoma

    Article • Medicine, October 2015, Wolters Kluwer Health

    Dr Chien-Wei Su

  115. Healthy Chinese with benign pancreatic hyperenzymemia

    Article • Journal of the Chinese Medical Association, October 2015, Wolters Kluwer Health

    Dr Chien-Wei Su

  116. Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients

    Article • PLOS One, September 2015, PLOS

    Dr Chien-Wei Su

  117. Low air temperature increases the risk of esophageal variceal bleeding

    Article • Liver International, September 2015, Wiley

    Mr. WEN-CHIEH WU, Dr Chien-Wei Su

  118. Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B

    Article • Medicine, August 2015, Wolters Kluwer Health

    Yi-Hsiang Huang, Dr Chien-Wei Su

  119. Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC System

    Article • Medicine, July 2015, Wolters Kluwer Health

    Dr Chien-Wei Su

  120. Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program

    Article • Hepatology, April 2015, Wiley

    Dr Chien-Wei Su

  121. Determinants of Survival After Sorafenib Failure in Patients With BCLC-C Hepatocellular Carcinoma in Real-World Practice

    Article • Medicine, April 2015, Wolters Kluwer Health

    Dr Chien-Wei Su, Yi-Hsiang Huang

  122. External Validation of Fatty Liver Index for Identifying Ultrasonographic Fatty Liver in a Large-Scale Cross-Sectional Study in Taiwan

    Article • PLOS One, March 2015, PLOS

    Dr Chien-Wei Su

  123. Radiofrequency Ablation is Better Than Surgical Resection in Patients With Hepatocellular Carcinoma Within the Milan Criteria and Preserved Liver Function

    Article • Journal of Clinical Gastroenterology, March 2015, Wolters Kluwer Health

    Dr Chien-Wei Su

  124. Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma

    Article • Journal of Surgical Oncology, February 2015, Wiley

    Dr Chien-Wei Su

  125. Vomiting and diarrhea in a woman with systemic lupus erythematosus

    Article • Journal of the Chinese Medical Association, February 2015, Wolters Kluwer Health

    Dr Chien-Wei Su

  126. Impact of Steatosis on Prognosis of Patients with Early-Stage Hepatocellular Carcinoma After Hepatic Resection

    Article • Annals of Surgical Oncology, December 2014, Springer Science + Business Media

    Dr Chien-Wei Su

  127. Uncompromised Treatment Efficacy in Elderly Patients With Hepatocellular Carcinoma

    Article • Medicine, December 2014, Wolters Kluwer Health

    Dr Chien-Wei Su

  128. A Comparison of Clinical Manifestations and Prognoses Between Patients with Hepatocellular Carcinoma and Child–Pugh Scores of 5 or 6

    Article • Medicine, December 2014, Wolters Kluwer Health

    Dr Chien-Wei Su

  129. Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B—A Nationwide Cohort Study

    Article • Gastroenterology, July 2014, Elsevier

    Dr Chien-Wei Su

  130. Endoscopic ultrasonography assessment of para-esophageal varices predicts efficacy of propranolol in preventing recurrence of esophageal varices

    Article • Journal of Gastroenterology, June 2014, Springer Science + Business Media

    Dr Chien-Wei Su

  131. A New Child-Turcotte-Pugh Class 0 for Patients with Hepatocellular Carcinoma: Determinants, Prognostic Impact and Ability to Improve the Current Staging Systems

    Article • PLOS One, June 2014, PLOS

    Dr Chien-Wei Su

  132. Application of serologic assays for diagnosing acute hepatitis E in national surveillance of a nonendemic area

    Article • Journal of Medical Virology, January 2014, Wiley

    Dr Chien-Wei Su

  133. Risk of oral antifungal agent‐induced liver injury in Taiwanese

    Article • British Journal of Clinical Pharmacology, December 2013, Wiley

    Dr Chien-Wei Su

  134. Differential roles of serum hepatitis B virus DNA and hepatitis B surface antigen level in predicting virological breakthrough in patients receiving lamivudine therapy

    Article • Journal of Gastroenterology and Hepatology, November 2013, Wiley

    Dr Chien-Wei Su

  135. Wandering abdominal pain due to a floating gallbladder

    Article • Digestive and Liver Disease, November 2013, Elsevier

    Dr Chien-Wei Su

  136. CXCL9 Associated with Sustained Virological Response in Chronic Hepatitis B Patients Receiving Peginterferon Alfa-2a Therapy: A Pilot Study

    Article • PLOS One, October 2013, PLOS

    Dr Chien-Wei Su

  137. Inverse Association between Hepatitis B Virus Infection and Fatty Liver Disease: A Large-Scale Study in Populations Seeking for Check-Up

    Article • PLOS One, August 2013, PLOS

    Dr Chien-Wei Su

  138. Serum interferon gamma level predicts recurrence in hepatocellular carcinoma patients after curative treatments

    Article • International Journal of Cancer, June 2013, Wiley

    Dr Chien-Wei Su

  139. The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy

    Article • PLOS One, June 2013, PLOS

    Dr Chien-Wei Su

  140. α-Fetoprotein-to-Total Tumor Volume Ratio Predicts Post-operative Tumor Recurrence in Hepatocellular Carcinoma

    Article • Journal of Gastrointestinal Surgery, April 2013, Elsevier

    Dr Chien-Wei Su

  141. IL28B Polymorphism Correlates with Active Hepatitis in Patients with HBeAg-Negative Chronic Hepatitis B

    Article • PLOS One, February 2013, PLOS

    Dr Chien-Wei Su

  142. Risk of Hepato-Biliary Cancer After Cholecystectomy: a Nationwide Cohort Study

    Article • Journal of Gastrointestinal Surgery, February 2013, Elsevier

    Dr Chien-Wei Su

  143. Hepatocellular carcinoma in uremic patients: Is there evidence for an increased risk of mortality?

    Article • Journal of Gastroenterology and Hepatology, January 2013, Wiley

    Dr Chien-Wei Su

  144. Second primary cancers in patients with hepatocellular carcinoma: a nationwide cohort study in Taiwan

    Article • Liver International, January 2013, Wiley

    Dr Chien-Wei Su

  145. Performance Status Enhances the Selection of Treatment for Patients with Hepatocellular Carcinoma Within the Milan Criteria

    Article • Annals of Surgical Oncology, January 2013, Springer Science + Business Media

    Dr Chien-Wei Su

  146. Forfeited hepatogenesis program and increased embryonic stem cell traits in young hepatocellular carcinoma (HCC) comparing to elderly HCC

    Article • BMC Genomics, January 2013, Springer Science + Business Media

    Dr Chien-Wei Su

  147. Performance status in patients with hepatocellular carcinoma: Determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system

    Article • Hepatology, January 2013, Wiley

    Dr Chien-Wei Su

  148. Milan Criteria, Multi-nodularity, and Microvascular Invasion Predict the Recurrence Patterns of Hepatocellular Carcinoma After Resection

    Article • Journal of Gastrointestinal Surgery, December 2012, Springer Science + Business Media

    Dr Chien-Wei Su

  149. Delayed endoscopy increases re-bleeding and mortality in patients with hematemesis and active esophageal variceal bleeding: A cohort study

    Article • Journal of Hepatology, December 2012, Elsevier

    Dr Chien-Wei Su

  150. Hepatic resection can provide long-term survival of patients with non–early-stage hepatocellular carcinoma: Extending the Indication for resection?

    Article • Surgery, November 2012, Elsevier

    Dr Chien-Wei Su

  151. Outcome After Percutaneous Cholecystostomy for Acute Cholecystitis: a Single-Center Experience

    Article • Journal of Gastrointestinal Surgery, October 2012, Elsevier

    Dr Chien-Wei Su

  152. Prognostic Significance of Computed Tomography Scan-derived Splenic Volume in Hepatocellular Carcinoma Treated With Radiofrequency Ablation

    Article • Journal of Clinical Gastroenterology, October 2012, Wolters Kluwer Health

    Dr Chien-Wei Su

  153. Selecting a prognostic renal surrogate for patients with hepatocellular carcinoma undergoing transarterial chemoembolization

    Article • Journal of Gastroenterology and Hepatology, September 2012, Wiley

    Dr Chien-Wei Su

  154. Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects

    Article • Alimentary Pharmacology & Therapeutics, July 2012, Wiley

    Dr Chien-Wei Su

  155. A prognostic model for patients with hepatocellular carcinoma within the Milan criteria undergoing non‐transplant therapies, based on 1106 patients

    Article • Alimentary Pharmacology & Therapeutics, July 2012, Wiley

    Dr Chien-Wei Su

  156. Cancer risk in patients with pyogenic liver abscess: a nationwide cohort study

    Article • Alimentary Pharmacology & Therapeutics, July 2012, Wiley

    Dr Chien-Wei Su

  157. Hepatitis D Virus Isolates with Low Replication and Epithelial-Mesenchymal Transition-Inducing Activity Are Associated with Disease Remission

    Article • Journal of Virology, June 2012, ASM Journals

    Dr Chien-Wei Su

  158. Alcoholism worsens the survival of patients with hepatitis B virus and C virus-related hepatocellular carcinoma

    Article • Hepatology International, May 2012, Springer Science + Business Media

    Dr Chien-Wei Su

  159. Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy

    Article • Clinical Radiology, May 2012, Elsevier

    Dr Chien-Wei Su

  160. The Effect of Age on the Long-term Prognosis of Patients With Hepatocellular Carcinoma After Resection Surgery

    Article • Archives of Surgery, February 2012, American Medical Association (AMA)

    Dr Chien-Wei Su

  161. Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy

    Article • Hepatology International, January 2012, Springer Science + Business Media

    Dr Chien-Wei Su

  162. Younger Hepatocellular Carcinoma Patients Have Better Prognosis After Percutaneous Radiofrequency Ablation Therapy

    Article • Journal of Clinical Gastroenterology, January 2012, Wolters Kluwer Health

    Dr Chien-Wei Su

  163. Impact of body mass index and viral load on liver histology in hepatitis B e antigen-negative chronic hepatitis B

    Article • Clinical Nutrition, October 2011, Elsevier

    Dr Chien-Wei Su

  164. Comparison of Surgical Resection and Transarterial Chemoembolization for Hepatocellular Carcinoma beyond the Milan Criteria: A Propensity Score Analysis

    Article • Annals of Surgical Oncology, September 2011, Springer Science + Business Media

    Dr Chien-Wei Su

  165. Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy

    Article • European Journal of Gastroenterology & Hepatology, May 2011, Wolters Kluwer Health

    Dr Chien-Wei Su

  166. Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria

    Article • Liver Transplantation, May 2011, Wolters Kluwer Health

    Dr Chien-Wei Su

  167. Early identification of poor responders to transarterial chemoembolization for hepatocellular carcinoma

    Article • Hepatology International, April 2011, Springer Science + Business Media

    Dr Chien-Wei Su

  168. Comparative Analysis of Noninvasive Models to Predict Early Liver Fibrosis in Hepatitis B e Antigen-negative Chronic Hepatitis B

    Article • Journal of Clinical Gastroenterology, March 2011, Wolters Kluwer Health

    Dr Chien-Wei Su

  169. A Comparison of Prognosis between Patients with Hepatitis B and C Virus‐related Hepatocellular Carcinoma Undergoing Resection Surgery

    Article • January 2011, Wiley

    Dr Chien-Wei Su

  170. Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy

    Article • Antiviral Therapy, January 2011, International Medical Press

    Dr Yi-Wen Huang, Dr Chien-Wei Su

  171. Survival Rates Are Comparable After Radiofrequency Ablation or Surgery in Patients With Small Hepatocellular Carcinomas

    Article • Clinical Gastroenterology and Hepatology, January 2011, Elsevier

    Dr Chien-Wei Su

  172. Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy

    Article • BMC Gastroenterology, December 2010, Springer Science + Business Media

    Dr Chien-Wei Su

  173. Fibrosis and AST to platelet ratio index predict post-operative prognosis for solitary small hepatitis B-related hepatocellular carcinoma

    Article • Hepatology International, September 2010, Springer Science + Business Media

    Dr Chien-Wei Su

  174. Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Renal Insufficiency

    Article • Journal of Clinical Gastroenterology, September 2010, Wolters Kluwer Health

    Dr Chien-Wei Su

  175. A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring system

    Article • Journal of Hepatology, July 2010, Elsevier

    Dr Chien-Wei Su

  176. Correlation between clinical indication for treatment and liver histology in HBeAg-negative chronic hepatitis B: a novel role of α-fetoprotein

    Article • Liver International, June 2010, Wiley

    Dr Chien-Wei Su

  177. The safety and probable therapeutic effect of routine use of antibiotics and simultaneously treating bleeding gastric varices by using endoscopic cyanoacrylate injection and concomitant esophageal varices with banding ligation: a pilot study

    Article • Gastrointestinal Endoscopy, June 2010, Elsevier

    Dr Chien-Wei Su

  178. Core Antigen Expression Is Associated with Hepatic Necroinflammation in e Antigen-Negative Chronic Hepatitis B Patients with Low DNA Loads

    Article • Clinical and Vaccine Immunology, April 2010, ASM Journals

    Dr Chien-Wei Su

  179. Selecting an optimal staging system for hepatocellular carcinoma

    Article • Cancer, March 2010, Wiley

    Dr Chien-Wei Su

  180. Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis

    Article • Digestive and Liver Disease, February 2010, Elsevier

    Dr Chien-Wei Su

  181. Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization

    Article • Liver International, January 2010, Wiley

    Dr Chien-Wei Su

  182. Pancreatic Duct Disruption With Autosplenectomy

    Article • Gastroenterology, December 2009, Elsevier

    Dr Chien-Wei Su

  183. Pro-205 of large hepatitis delta antigen and Pro-62 of major hepatitis B surface antigen influence the assembly of different genotypes of hepatitis D virus

    Article • Journal of General Virology, November 2009, Society for General Microbiology

    Dr Chien-Wei Su

  184. Abdominal Pain After Endoscopic Hemostasis of Gastric Tumor Bleeding

    Article • Gastroenterology, November 2009, Elsevier

    Dr Chien-Wei Su

  185. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma

    Article • Journal of Hepatology, November 2009, Elsevier

    Dr Chien-Wei Su

  186. Gastrointestinal bleeding because of hookworm infection diagnosed by capsule endoscopy

    Article • European Journal of Gastroenterology & Hepatology, October 2009, Wolters Kluwer Health

    Dr Chien-Wei Su

  187. Predictive Value of Aspartate Aminotransferase to Alanine Aminotransferase Ratio for Hepatic Fibrosis and Clinical Adverse Outcomes in Patients With Primary Biliary Cirrhosis

    Article • Journal of Clinical Gastroenterology, October 2009, Wolters Kluwer Health

    Dr Chien-Wei Su

  188. Hepatogastric Fistula in One Patient With Liver Abscess

    Article • Gastroenterology, September 2009, Elsevier

    Dr Chien-Wei Su

  189. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma

    Article • Hepatology, August 2009, Wiley

    Dr Chien-Wei Su

  190. Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection?

    Article • Liver International, May 2009, Wiley

    Dr Chien-Wei Su

  191. Clinical Challenges and Images in GI

    Article • Gastroenterology, April 2009, Elsevier

    Dr Chien-Wei Su

  192. Generation of cytotoxicity against hepatitis delta virus genotypes and quasispecies by epitope modification

    Article • Journal of Hepatology, April 2009, Elsevier

    Dr Chien-Wei Su

  193. Autoimmune hepatitis combined with multiple viral infections

    Article • European Journal of Gastroenterology & Hepatology, November 2008, Wolters Kluwer Health

    Dr Chien-Wei Su

  194. Is entecavir ideal for the treatment of lamivudine-refractory chronic hepatitis B?

    Article • Hepatology, July 2008, Wiley

    Dr Chien-Wei Su

  195. Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years

    Article • Liver International, March 2008, Wiley

    Dr Chien-Wei Su

  196. Validation of the HCC-MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy

    Article • Clinical Transplantation, March 2008, Wiley

    Dr Chien-Wei Su

  197. Hepatitis B Surface Antigen Levels and Sequences of Natural Hepatitis B Virus Variants Influence the Assembly and Secretion of Hepatitis D Virus

    Article • Journal of Virology, December 2007, ASM Journals

    Dr Chien-Wei Su

  198. Positive Selection of Hepatitis Delta Antigen in Chronic Hepatitis D Patients

    Article • Journal of Virology, February 2007, ASM Journals

    Dr Chien-Wei Su

  199. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients

    Article • Journal of Viral Hepatitis, May 2006, Wiley

    Dr Chien-Wei Su

  200. Genotypes and Viremia of Hepatitis B and D Viruses Are Associated With Outcomes of Chronic Hepatitis D Patients

    Article • Gastroenterology, May 2006, Elsevier

    Dr Chien-Wei Su

  201. Analysis of clinical, biochemical and viral factors associated with early relapse after lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B patients in Taiwan

    Article • Journal of Viral Hepatitis, July 2003, Wiley

    Dr Chien-Wei Su

  202. Comparison of clinical manifestations and epidemiology between acute hepatitis A and acute hepatitis E in Taiwan

    Article • Journal of Gastroenterology and Hepatology, November 2002, Wiley

    Dr Chien-Wei Su